A multi-centre, double-blind randomized study to assess the efficacy and tolerance of sulindac versus placebo in the symptomatic treatment of patients with upper respiratory tract infection.

Source:http://linkedlifedata.com/resource/pubmed/id/3907988

Download in:

View as

General Info

PMID
3907988